Unique positioning: short tripeptide, exceptional copper stability, 50-year corpus, commercial cosmetic use integrated since the 1990s, broadest documented genomic modulation for a peptide
Based on the data available in 2015, EFSA did not identify any known health risks associated with the use of dietary supplements, so no maximum dose or maximum daily intake, also known as a tolerable upper intake, was set (EFSA, 2015)
Critically, the peptide showed therapeutic efficacy even when administered after neurotoxin exposure
Six months in now and the transformation in my confidence is just as significant as the physical changes
Important Notice This product is intended strictly for in vitro research and laboratory use only